Mylan has been harshly criticized for jacking up the price of the EpiPen from $57 to around $600, and even Congress is getting involved.
But now the company seems to be offering a concession: It will start selling a generic EpiPen for half the cost, according to a company statement. That amounts to $300 for a pack of two injectors, which is still a significant increase over the $57 initial price back in 2007 when it bought the drug.
We understand the deep frustration and concerns associated with the cost of EpiPen to the patient.
The company said this would complement, rather than replace, a $300 "My EpiPen Savings Card" that can be used at pharmacies.
The generic EpiPen would come in 0.15 and 0.3 mg strengths and should arrive "in several weeks." The non-generic EpiPen will stay on the market.
There are already alternative EpiPens, but they haven't sold well despite being significantly cheaper. Sen. Amy Klobuchar asked the FTC to investigate whether Mylan blocked competitors like AdrenaClick.
You can see a generic version of AdrenaClick tested above.
What remains unclear is if Congress will take any action. Both Republicans and Democrats have raised concerns over the pricing, but no hearings have been scheduled. CEO Heather Bresch is the daughter of West Virginia democrat Sen. Joe Manchin.
Actress Sarah Jessica Parker cut her ties with Mylan last week.